Publications 2014

1. Owusu M, Annan A, Corman VM, Larbi R, Anti P, Drexler JF, Agbenyega O, Adu-Sarkodie Y, Drosten C. Human coronaviruses associated with upper respiratory tract infections in three rural areas of Ghana. PLoS One. 2014 Jul 31;9 (7):e99782.

2. Afum-Adjei Awuah A, Ueberberg B, Owusu-Dabo E, Frempong M, Jacobsen M. Dynamics of T-cell IFN-γ and miR-29a expression during active pulmonary tuberculosis. Int Immunol. 2014 , 26(10):579-82.

3. Torgbor C, Awuah P, Deitsch K, Kalantari P, Duca KA, Thorley-Lawson DA. A multifactorial role for P. falciparum malaria in endemic Burkitt’s lymphoma pathogenesis. PLoS Pathog. 2014, 10(5): e1004170.

4. Phillips RO, Sarfo FS, Landier J, Oldenburg R, Frimpong M, Wansbrough-Jones M, Abass K, Thompson W, Forson M, Fontanet A, Niang F, Demangel C. Combined inflammatory and metabolic defects reflected by reduced serum protein levels in patients with Buruli ulcer disease. PLoS Negl Trop Dis. 2014;8(4):e 2786.

5. Arndts K, Specht S, Debrah AY, Tamarozzi F, Klarmann Schulz U, Mand S, Batsa L, Kwarteng A, Taylor M, Adjei O, Martin C, Layland LE, Hoerauf A. Immunoepidemiological profiling of onchocerciasis patients reveals associations with microfilaria loads and ivermectin intake on both individual and community levels. PLoS Negl Trop Dis. 2014;8(2): e2679.

6. Vandelannoote K, Jordaens K, Bomans P, Leirs H, Durnez L, Affolabi D, Sopoh G, Aguiar J, Phanzu DM, Kibadi K, Eyangoh S, Manou LB, Phillips RO, Adjei O, Ablordey A, Rigouts L, Portaels F, Eddyani M, and de Jong BC. Evolutionary and genomic microbiology insertion sequence element single nucleotide polymorphism typing provides insights into the population structure and evolution of Mycobacterium ulcerans across Africa. Appl. Environ. Microbiol. 2014, 80:3 1197-1209

7. Esser, C., Bachmann, A., Kuhn, D., Schuldt, K., Förster, B., Thiel, M., May, J., Koch-Nolte, F., Yáñez-Mó, M., Sánchez-Madrid, F., Schinkel, A. H., Jalkanen, S., Craig, A. G., Bruchhaus, I. and Horstmann, R. D. Evidence of promiscuous endothelial binding by Plasmodium falciparum-infected erythrocytes. Cellular Microbiology, 2014, (16): 701–708.

8. Sarfo FS, Sarfo MA, Norman B, Phillips R, Chadwick D. Incidence and Determinants of Nevirapine and Efavirenz-Related Skin Rashes in West Africans: Nevirapine’s Epitaph? PloS one, 2014 DOI: 10.1371/journal.pone.0094854

9. Sarfo FS, Sarfo MA, Norman B, Phillips R, Bedu-Addo G, Chadwick D. Risk of Deaths, AIDS-Defining and Non-AIDS Defining Events among Ghanaians on Long-Term Combination Antiretroviral Therapy PloS one, 2014 DOI: 10.1371/journal.pone.0111400

10. Schuldt K, Evans J, Lenzen J, Ehmen C, Mantau B, Sieversten J, Enuameh Y, Osei-Kwakye K, Opoku EC, Browne ENL, Horstmann R, Timann C. Disentangling malaria anaemia. 2014 Malaria Journal (13) Suppl 1.

11. Messersmith L, Beard J, Agyarko-Poku T, Longobardi D, Asafo M, Corneliess C, Daube E, Ashigbie P, Falconer A, Adu-Sarkodie Y. “I can decide to use the property I have to make money”: HIV Vulneability of Bar Workers and Bar Patrons in Kumasi, Ghana. Center for Global Health and Development 2014 – bu.edu

12. Poku T, Longobardi D, Asafo M, Corneliess C, Daube E, Ashigbie P, Falconer A, Adu-Sarkodie Y. HIV Vulnerability of men and women who inject drugs in Kumasi, Ghana. Center for Global Health and Development 2014 – bu.edu

13. Onyango MA, Adu-Sarkodie Y, Adjei R, Agyarko-Poku T, Greem K, Wambugu S, Falconer A, Kopelman CH, Beard J. Understanding the Relationship Dynamics between Female Sex Workers and Their Intimate Partners in Kumasi, Ghana.Center for Global Health and Development 2014

14. Schuldt K, Ehmen C, Evans J, May J, Ansong D, Sievertsen J, Muntau B, Ruge G, Agbenyega T, Horstmann RD. Endothelial protein C receptor gene variants not associated with severe malaria in ghanaian children.PLoS One. 2014 Dec 26;9(12):e115770. doi: 10.1371/journal.pone.0115770.

15. Brinkel J, Krämer A, Krumkamp R, May J, Fobil J. Mobile phone-based mHealth approaches for public health surveillance in sub-Saharan Africa: a systematic review. Int J Environ Res Public Health. 2014,11(11):11559-82.

16. Maganga GD, Bourgarel M, Obame Nkoghe J, N’Dilimabaka N, Drosten C, Paupy C, Morand S, Drexler JF, Leroy EM. Identification of an unclassified paramyxovirus in Coleura afra: a potential case of host specificity. PLoS One. 2014; 9(12):e115588. doi: 10.1371/journal.pone.0115588.

17. Müller MA, Corman VM, Jores J, Meyer B, Younan M, Liljander A, Bosch BJ, Lattwein E, Hilali M, Musa BE, Bornstein S, Drosten C. MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983-1997. Emerg Infect Dis. 2014, 20(12):2093-5.

18. Drosten C. Virus ecology: studying animal reservoirs to understand viral emergence.Drug Res (Stuttg). 2014 Nov;64 Suppl 1:S27. doi: 10.1055/s-0033-1358040.

19. Kallies R, Kopp A, Zirkel F, Estrada A, Gillespie TR, Drosten C, Junglen S. Genetic characterization of goutanap virus, a novel virus related to negeviruses, cileviruses and higreviruses. Viruses. 2014, 6(11):4346-57.

20. Drosten C, Kellam P, Memish ZA. Evidence for camel-to-human transmission of MERS coronavirus. N Engl J Med. 2014; 371(14):1359-60.

21. Schuster S, Zirkel F, Kurth A, van Cleef KW, Drosten C, van Rij RP, Junglen S. A unique nodavirus with novel features: mosinovirus expresses two subgenomic RNAs, a capsid gene of unknown origin, and a suppressor of the antiviral RNA interference pathway. J Virol. 2014 Nov; 88(22):13447-59.

22. Zumla A, Al-Tawfiq JA, Enne VI, Kidd M, Drosten C, Breuer J, Muller MA, Hui D, Maeurer M, Bates M, Mwaba P, Al-Hakeem R, Gray G, Gautret P, Al-Rabeeah AA, Memish ZA, Gant V. Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections–needs, advances, and future prospects. Lancet Infect Dis. 2014 Nov;14(11):1123-35. doi: 10.1016/S1473-3099(14)70827-8.

23. Baldwin HJ, Vallo P, Gardner MG, Drosten C, Tschapka M, Stow AJ. Isolation and characterization of 11 novel microsatellite loci in a West African leaf-nosed bat, Hipposideros aff. ruber. BMC Res Notes. 2014 Sep 4;7:607. doi: 10.1186/1756-0500-7-607.

24. Drosten C, Meyer B, Müller MA, Corman VM, Al-Masri M, Hossain R, Madani H, Sieberg A, Bosch BJ, Lattwein E, Alhakeem RF, Assiri AM, Hajomar W, Albarrak AM, Al-Tawfiq JA, Zumla AI, Memish ZA. Transmission of MERS-coronavirus in household contacts. N Engl J Med. 2014; 371(9):828-35.

25. Drexler JF, Grard G, Lukashev AN, Kozlovskaya LI, Böttcher S, Uslu G, Reimerink J, Gmyl AP, Taty-Taty R, Lekana-Douki SE, Nkoghe D, Eis-Hübinger AM, Diedrich S, Koopmans M, Leroy EM, Drosten C. Robustness against serum neutralization of a poliovirus type 1 from a lethal epidemic of poliomyelitis in the Republic of Congo in 2010. Proc Natl Acad Sci U S A. 2014, 111(35):12889-94.

26. Krüger N, Hoffmann M, Drexler JF, Müller MA, Corman VM, Drosten C, Herrler G. Attachment protein G of an African bat henipavirus is differentially restricted in chiropteran and nonchiropteran cells. J Virol. 2014, 88(20):11973-80.

27. Corman VM, Jores J, Meyer B, Younan M, Liljander A, Said MY, Gluecks I, Lattwein E, Bosch BJ, Drexler JF, Bornstein S, Drosten C, Müller MA. Antibodies against MERS coronavirus in dromedary camels, Kenya, 1992-2013. Emerg Infect Dis. 2014, 20(8):1319-22.

28. Bouvet M, Lugari A, Posthuma CC, Zevenhoven JC, Bernard S, Betzi S, Imbert I, Canard B, Guillemot JC, Lécine P, Pfefferle S, Drosten C, Snijder EJ, Decroly E, Morelli X. Coronavirus Nsp10, a critical co-factor for activation of multiple replicative enzymes.J Biol Chem. 2014, 289(37):25783-96.

29. Doherty ML, Owusu-Dabo E, Kantanka OS, Brawer RO, Plumb JD. Type 2 diabetes in a rapidly urbanizing region of Ghana, West Africa: a qualitative study of dietary preferences, knowledge and practices. BMC Public Health. 2014, 14:1069. doi: 10.1186/1471-2458-14-1069.

30. H3Africa Consortium, Rotimi C, Abayomi A, Abimiku A, Adabayeri VM, Adebamowo C, Adebiyi E, Ademola AD, Adeyemo A, Adu D, Affolabi D, Agongo G, Ajayi S, Akarolo-Anthony S, Akinyemi R, Akpalu A, Alberts M, Alonso Betancourt O, Alzohairy AM, Ameni G, Amodu O, Anabwani G, Andersen K, Arogundade F, Arulogun O, Asogun D, Bakare R, Balde N, Baniecki ML, Beiswanger C, Benkahla A, Bethke L, Boehnke M, Boima V, Brandful J, Brooks AI, Brosius FC, Brown C, Bucheton B, Burke DT, Burnett BG, Carrington-Lawrence S, Carstens N, Chisi J, Christoffels A, Cooper R, Cordell H, Crowther N, Croxton T, de Vries J, Derr L, Donkor P, Doumbia S, Duncanson A, Ekem I, El Sayed A, Engel ME, Enyaru JC, Everett D, Fadlelmola FM, Fakunle E, Fischbeck KH, Fischer A, Folarin O, Gamieldien J, Garry RF, Gaseitsiwe S, Gbadegesin R, Ghansah A, Giovanni M, Goesbeck P, Gomez-Olive FX, Grant DS, Grewal R, Guyer M, Hanchard NA, Happi CT, Hazelhurst S, Hennig BJ, Hertz- C, Fowler, Hide W, Hilderbrandt F, Hugo-Hamman C, Ibrahim ME, James R, Jaufeerally-Fakim Y, Jenkins C, Jentsch U, Jiang PP, Joloba M, Jongeneel V, Joubert F, Kader M, Kahn K, Kaleebu P, Kapiga SH, Kassim SK, Kasvosve I, Kayondo J, Keavney B, Kekitiinwa A, Khan SH, Kimmel P, King MC, Kleta R, Koffi M, Kopp J, Kretzler M, Kumuthini J, Kyobe S, Kyobutungi C, Lackland DT, Lacourciere KA, Landouré G, Lawlor R, Lehner T, Lesosky M, Levitt N, Littler K, Lombard Z, Loring JF, Lyantagaye S, Macleod A, Madden EB, Mahomva CR, Makani J, Mamven M, Marape M, Mardon G, Marshall P, Martin DP, Masiga D, Mason R, Mate-Kole M, Matovu E, Mayige M, Mayosi BM, Mbanya JC, McCurdy SA, McCarthy MI, McIlleron H, Mc’Ligeyo SO, Merle C, Mocumbi AO, Mondo C, Moran JV, Motala A, Moxey-Mims M, Mpoloka WS, Msefula CL, Mthiyane T, Mulder N, Mulugeta Gh, Mumba D, Musuku J, Nagdee M, Nash O, Ndiaye D, Nguyen AQ, Nicol M, Nkomazana O, Norris S, Nsangi B, Nyarko A, Nyirenda M, Obe E, Obiakor R, Oduro A, Ofori-Acquah SF, Ogah O, Ogendo S, Ohene-Frempong K, Ojo A, Olanrewaju T, Oli J, Osafo C, Ouwe Missi Oukem-Boyer O, Ovbiagele B, Owen A, Owolabi MO, Owolabi L, Owusu-Dabo E, Pare G, Parekh R, Patterton HG, Penno MB, Peterson J, Pieper R, Plange-Rhule J, Pollak M, Puzak J, Ramesar RS, Ramsay M, Rasooly R, Reddy S, Sabeti PC, Sagoe K, Salako T, Samassékou O, Sandhu MS, Sankoh O, Sarfo FS, Sarr M, Shaboodien G, Sidibe I, Simo G, Simuunza M, Smeeth L, Sobngwi E, Soodyall H, Sorgho H, Sow Bah O, Srinivasan S, Stein DJ, Susser ES, Swanepoel C, Tangwa G, Tareila A, Tastan Bishop O, Tayo B, Tiffin N, Tinto H, Tobin E, Tollman SM, Traoré M, Treadwell MJ, Troyer J, Tsimako-Johnstone M, Tukei V, Ulasi I, Ulenga N, van Rooyen B, Wachinou AP, Waddy SP, Wade A, Wayengera M, Whitworth J, Wideroff L, Winkler CA, Winnicki S, Wonkam A, Yewondwos M, sen T, Yozwiak N, Zar H. Research capacity. Enabling the genomic revolution in Africa. Science. 2014; 344(6190):1346-8.

31. Agyemang C, Beune E, Meeks K, Owusu-Dabo E, Agyei-Baffour P, Aikins Ad, Dodoo F, Smeeth L, Addo J, Mockenhaupt FP, Amoah SK, Schulze MB, Danquah I, Spranger J, Nicolaou M, Klipstein-Grobusch K, Burr T, Henneman P, Mannens MM, van Straalen JP, Bahendeka S, Zwinderman AH, Kunst AE, Stronks K. Rationale and cross-sectional study design of the Research on Obesity and type 2 Diabetes among African Migrants: the RODAM study. BMJ Open. 2014, 4(3):e004877. doi: 10.1136/bmjopen-2014-004877.

32. Pool MS, Otupiri E, Owusu-Dabo E, de Jonge A, Agyemang C. Physical violence during pregnancy and pregnancy outcomes in Ghana. BMC Pregnancy Childbirth. 2014,14:71. doi: 10.1186/1471-2393-14-71.

33. Layden JE, Phillips RO, Owusu-Ofori S, Sarfo FS, Kliethermes S, Mora N, Owusu D, Nelson K, Opare-Sem O, Dugas L, Luke A, Shoham D, Forbi JC, Khudyakov YE, Cooper RS. High Frequency of Active HCV Infection Among Seropositive Cases in West Africa and Evidence for Multiple Transmission Pathways. Clin Infect Dis. 2014. pii: ciu965.

34. King S, Adjei-Asante K, Appiah L, Adinku D, Beloukas A, Atkins M, Sarfo SF, Chadwick D, Phillips RO, Geretti AM. Antibody screening tests variably overestimate the prevalence of hepatitis C virus infection among HIV-infected adults in Ghana. J Viral Hepat. 2014 doi: 10.1111/jvh.12354.

35. de Zeeuw J, Douwstra M, Omansen TF, Sopoh GE, Johnson C, Phillips RO, Alferink M, Saunderson P, Van der Werf TS, Dijkstra PU, Stienstra Y. Psychometric properties of the participation scale among former buruli ulcer patients in Ghana and Benin. PLoS Negl Trop Dis. 2014;8(11):e3254. doi: 10.1371/journal.pntd.0003254.

36. de Zeeuw J, Omansen TF, Douwstra M, Barogui YT, Agossadou C, Sopoh GE, Phillips RO, Johnson C, Abass KM, Saunderson P, Dijkstra PU, van der Werf TS, Stientstra Y. Persisting social participation restrictions among former buruli ulcer patients in Ghana and Benin. PLoS Negl Trop Dis. 2014; 8(11):e3303. doi: 10.1371/journal.pntd.0003303..

37. Phillips RO, Sarfo FS, Abass MK, Frimpong M, Ampadu E, Forson M, Amoako YA, Thompson W, Asiedu K, Wansbrough-Jones M. Reply to “compliance with antimicrobial therapy for buruli ulcer”. Antimicrob Agents Chemother. 2014;58(10):6341.

38. Klis S, Ranchor A, Phillips RO, Abass KM, Tuah W, Loth S, Velding K, van der Werf TS, Stienstra Y. Good quality of life in former Buruli ulcer patients with small lesions: long-term follow-up of the BURULICO trial. PLoS Negl Trop Dis. 2014;8(7):e2964. doi: 10.1371/journal.pntd.0002964..

39. Klis S, van der Werf TS, Phillips RO, Sarfo FS, Wansbrough-Jones M, Stienstra Y. Oral treatment for patients with Buruli ulcer co-infected with HIV: think twice. AIDS. 2014; 28(5):797-8.

40. Sarfo FS, Thompson W, Phillips RO, Paintsil A, Abass MK, Frimpong M, Abotsi J, Asiedu K, Wansbrough-Jones MH. A severe case of Buruli ulcer disease with pleural effusions. PLoS Negl Trop Dis. 2014;8(6):e2868. doi: 10.1371/journal.pntd.0002868.

41. Phillips RO, Frimpong M, Sarfo FS, Kretschmer B, Beissner M, Debrah A, Ampem-Amoako Y, Abass KM, Thompson W, Duah MS, Abotsi J, Adjei O, Fleischer B, Bretzel G, Wansbrough-Jones M, Jacobsen M. Infection with Mansonella perstans Nematodes in Buruli Ulcer Patients, Ghana. Emerg Infect Dis. 2014 ;20(6):1000-3.

42. Sarfo FS, Phillips RO, Zhang J, Abass MK, Abotsi J, Amoako YA, Adu-Sarkodie Y, Robinson C, Wansbrough-Jones MH. Kinetics of mycolactone in human subcutaneous tissue during antibiotic therapy for Mycobacterium ulcerans disease. BMC Infect Dis. 2014; 14:202. doi: 10.1186/1471-2334-14-202.

43. Phillips RO, Sarfo FS, Landier J, Oldenburg R, Frimpong M, Wansbrough-Jones M, Abass K, Thompson W, Forson M, Fontanet A, Niang F, Demangel C. Combined inflammatory and metabolic defects reflected by reduced serum protein levels in patients with Buruli ulcer disease. PLoS Negl Trop Dis. 2014;8(4):e2786. doi: 10.1371/journal.pntd.0002786.

44. Klis S, Stienstra Y, Phillips RO, Abass KM, Tuah W, van der Werf TS. Long term streptomycin toxicity in the treatment of Buruli Ulcer: follow-up of participants in the BURULICO drug trial. PLoS Negl Trop Dis. 2014 Mar 13;8(3):e2739. doi: 10.1371/journal.pntd.0002739.

45. Jansson M, Beissner M, Phillips RO, Badziklou K, Piten E, Maman I, Sarfo FS, Huber KL, Rhomberg A, Symank D, Wagner M, Wiedemann F, Nitschke J, Banla Kere A, Herbinger KH, Adjei O, Löscher T, Bretzel G. Comparison of two assays for molecular determination of rifampin resistance in clinical samples from patients with Buruli ulcer disease. J Clin Microbiol. 2014; 52(4):1246-9.

46. Phillips RO, Sarfo FS, Abass MK, Abotsi J, Wilson T, Forson M, Amoako YA, Thompson W, Asiedu K, Wansbrough-Jones M. Clinical and bacteriological efficacy of rifampicin-streptomycin combination for two weeks followed by rifampicin and clarithromycin for six weeks for treatment of Mycobacterium ulcerans disease Antimicrob Agents Chemother. 2014;58(2):1161-6. doi: 10.1128/AAC.02165-13. Epub 2013 Dec 9. Erratum in: Antimicrob Agents Chemother. 2014 58(4): 2488.

47. Vandelannoote K, Jordaens K, Bomans P, Leirs H, Durnez L, Affolabi D, Sopoh G, Aguiar J, Phanzu DM, Kibadi K, Eyangoh S, Manou LB, Phillips RO, Adjei O, Ablordey A, Rigouts L, Portaels F, Eddyani M, de Jong BC. Insertion sequence element single nucleotide polymorphism typing provides insights into the population structure and evolution of Mycobacterium ulcerans across Africa. Appl Environ Microbiol. 2014; 80(3):1197-209.

48. Rolling T, Agbenyega T, Issifou S, Adegnika AA, Sylverken J, Spahlinger D, Ansong D, Lohr SJ, Burchard GD, May J, MOrdmuller B, Krishna S, Kremsner PG, Cramer JP. Delayed hemolysis after treatment with parenteral artesuntae in African children with sever malaria-a double-centre prospective study. J Infect Dis. 2014; 209 (12): 1924-8

49. Bristow CC, Adu-Sarkodie Y, Ondondo RO, Bukusi EA, Dagnra CA, Oo KY, Pe EH, Khamsay C, Houng le T, Campuzano RV, Estes J, Klausner JD. Multi-site Laboratory Evaluation of a Dual Human Immunodeficiency Virus (HIV)/Syphilis Point-of-Care Rapid Test for Simultaneous Detection of HIV and Syphilis Infection. Open Forum Infect Dis. 2014; 1(1):ofu015. doi: 10.1093/ofid/ofu015. Mar.

50. Arndts K, Specht S, Debrah AY, Tamarozzi F, Klarmann Schulz U, Mand S, Batsa L, Kwarteng A, Taylor M, Adjei O, Martin C, Layland LE, Hoerauf A. Immunoepidemiological profiling of onchocerciasis patients reveals associations with microfilaria loads and ivermectin intake on both individual and community levels. PLoS Negl Trop Dis. 2014 Feb 20;8(2):e2679.

51. Coffeng LE, Stolk WA, Hoerauf A, Habbema D, Bakker R, Hopkins AD, de Vlas SJ. Elimination of African onchocerciasis: modeling the impact of increasing the frequency of ivermectin mass treatment. PLoS One. 2014 Dec 29;9(12):e115886. doi: 10.1371/journal.pone.0115886. eCollection 2014.

52. Johnston KL, Ford L, Umareddy I, Townson S, Specht S, Pfarr K, Hoerauf A, Altmeyer R, Taylor MJ. Repurposing of approved drugs from the human pharmacopoeia to target Wolbachia endosymbionts of onchocerciasis and lymphatic filariasis. Int J Parasitol Drugs Drug Resist. 2014 Sep 16;4(3):278-86. doi: 10.1016/j.ijpddr.2014.09.001. eCollection 2014 Dec.

53. Lentz CS, Sattler JM, Fendler M, Gottwalt S, Halls VS, Strassel S, Arriens S, Hannam JS, Specht S, Famulok M, Mueller AK, Hoerauf A, Pfarr KM. In vitro activity of wALADin benzimidazoles against different life cycle stages of Plasmodium parasites. Antimicrob Agents Chemother. 2015 Jan;59(1):654-8. doi: 10.1128/AAC.02383-14. Epub 2014 Oct 13.

54. Lutz P, Berger C, Langhans B, Grünhage F, Appenrodt B, Nattermann J, Lammert F, Hoerauf A, Sauerbruch T, Strassburg CP, Spengler U, Nischalke HD. A farnesoid X receptor polymorphism predisposes to spontaneous bacterial peritonitis. Dig Liver Dis. 2014 Nov;46(11):1047-50. doi: 10.1016/j.dld.2014.07.008. Epub 2014 Jul 30.

55. Lutz P, Parcina M, Bekeredjian-Ding I, Nischalke HD, Nattermann J, Sauerbruch T, Hoerauf A, Strassburg CP, Spengler U. Impact of rifaximin on the frequency and characteristics of spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites. PLoS One. 2014 Apr 8;9(4):e93909. doi: 10.1371/journal.pone.0093909. eCollection 2014.

56. Albers A, Sartono E, Wahyuni S, Yazdanbakhsh M, Maizels RM, Klarmann-Schulz U, Pfarr K, Hoerauf A. Real-time PCR detection of the HhaI tandem DNA repeat in pre- and post-patent Brugia malayi Infections: a study in Indonesian transmigrants. Parasit Vectors. 2014 Mar 31;7:146. doi: 10.1186/1756-3305-7-146.

57. Ajendra J, Specht S, Neumann AL, Gondorf F, Schmidt D, Gentil K, Hoffmann WH, Taylor MJ, Hoerauf A, Hübner MP. ST2 deficiency does not impair type 2 immune responses during chronic filarial infection but leads to an increased microfilaremia due to an impaired splenic microfilarial clearance. PLoS One. 2014 Mar 24;9(3):e93072. doi: 10.1371/journal.pone.0093072. eCollection 2014.

58. Arndts K, Specht S, Debrah AY, Tamarozzi F, Klarmann Schulz U, Mand S, Batsa L, Kwarteng A, Taylor M, Adjei O, Martin C, Layland LE, Hoerauf A. Immunoepidemiological profiling of onchocerciasis patients reveals associations with microfilaria loads and ivermectin intake on both individual and community levels. PLoS Negl Trop Dis. 2014 Feb 20;8(2):e2679.

59. Lentz CS, Halls VS, Hannam JS, Strassel S, Lawrence SH, Jaffe EK, Famulok M, Hoerauf A, Pfarr KM. wALADin benzimidazoles differentially modulate the function of porphobilinogen synthase orthologs. J Med Chem. 2014 Mar 27;57(6):2498-510. doi: 10.1021/jm401785n. Epub 2014 Feb 25.

60. Arumugam S, Hoerauf A, Pfarr KM. Localization of a filarial phosphate permease that is up-regulated in response to depletion of essential Wolbachia endobacteria. Exp Parasitol. 2014 Mar;138:30-9. doi: 10.1016/j.exppara.2014.01.006. Epub 2014 Jan 28.

61. Gentil K, Lentz CS, Rai R, Muhsin M, Kamath AD, Mutluer O, Specht S, Hübner MP, Hoerauf A. Eotaxin-1 is involved in parasite clearance during chronic filarial infection. Parasite Immunol. 2014 Feb;36(2):60-77. doi: 10.1111/pim.12079.

62. Schäberle TF, Schiefer A, Schmitz A, König GM, Hoerauf A, Pfarr K. Corallopyronin A – a promising antibiotic for treatment of filariasis. Int J Med Microbiol. 2014 Jan;304(1):72-8.

63. Taylor MJ, Hoerauf A, Townson S, Slatko BE, Ward SA. Anti-Wolbachia drug discovery and development: safe macrofilaricides for onchocerciasis and lymphatic filariasis. Parasitology. 2014 Jan;141(1):119-27. doi: 10.1017/S0031182013001108. Epub 2013 Jul 18. Review.

64. Adjobimey T, Satoguina J, Oldenburg J, Hoerauf A, Layland LE. Co-activation through TLR4 and TLR9 but not TLR2 skews Treg-mediated modulation of Igs and induces IL-17 secretion in Treg: B cell co-cultures. Innate Immun. 2014 Jan;20(1):12-23. doi: 10.1177/1753425913479414. Epub 2013 Mar 25.

65. Lutz P, Parcina M, Bekeredjian-Ding I, Hoerauf A, Strassburg CP, Spengler U. Spontaneous bacterial peritonitis by Pasteurella multocida under treatment with rifaximin. Infection. 2014 Feb;42(1):175-7. doi: 10.1007/s15010-013-0449-4. Epub 2013 Mar 25.